{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:41:01Z","timestamp":1793742061875,"version":"4.6.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.vhri.2025.101167","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:00:51Z","timestamp":1756382451000},"page":"101167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Impact of Severe Hemophilia on Costs and Quality of Life in South American Men: Findings From the CHESS LATAM Study"],"prefix":"10.1016","volume":"50","author":[{"given":"Jonathan","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Skerritt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idaira","family":"Rodriguez Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania Onzi","family":"Pietrobelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Robledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Gomez","family":"Cavallini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Neme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Khair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Finnegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.vhri.2025.101167_bib1","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM200106073442307","article-title":"The hemophilias\u2014from royal genes to gene therapy","volume":"344","author":"Mannucci","year":"2001","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vhri.2025.101167_bib2","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/jth.15397","article-title":"A new hemophilia carrier nomenclature to define hemophilia in women and girls: communication from the SSC of the ISTH","volume":"19","author":"van Galen","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"8","key":"10.1016\/j.vhri.2025.101167_bib3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.7326\/M19-1208","article-title":"Establishing the prevalence and prevalence at birth of hemophilia in males: a meta-analytic approach using national registries","volume":"171","author":"Iorio","year":"2019","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.vhri.2025.101167_bib5","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/hae.13214","article-title":"Self-reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the P-FiQ study","volume":"23","author":"Witkop","year":"2017","journal-title":"Haemophilia"},{"key":"10.1016\/j.vhri.2025.101167_bib6","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.2147\/PPA.S212723","article-title":"Interrelationship between depression, anxiety, pain, and treatment adherence in hemophilia: results from a US cross-sectional survey","volume":"13","author":"Witkop","year":"2019","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"10.1016\/j.vhri.2025.101167_bib7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12955-018-0908-9","article-title":"The impact of severe haemophilia and the presence of target joints on health-related quality of life","volume":"16","author":"O\u2019Hara","year":"2018","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"10.1016\/j.vhri.2025.101167_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13561-018-0185-7","article-title":"The relationship between target joints and direct resource use in severe haemophilia","volume":"8","author":"O\u2019Hara","year":"2018","journal-title":"Health Econ Rev"},{"issue":"6","key":"10.1016\/j.vhri.2025.101167_bib9","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/hae.13456","article-title":"International haemophilia access strategy. Patient-centred value framework for haemophilia","volume":"24","author":"O\u2019Mahony","year":"2018","journal-title":"Haemophilia"},{"issue":"24","key":"10.1016\/j.vhri.2025.101167_bib10","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.3390\/jcm10245959","article-title":"Real-world rates of bleeding, factor VIII use, and quality of life in individuals with severe haemophilia A receiving prophylaxis in a prospective, noninterventional study","volume":"10","author":"Kenet","year":"2021","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.vhri.2025.101167_bib11","article-title":"The relationship between specific annual bleed rates and health outcomes among children with severe hemophilia A in Latin America","volume":"16","author":"Bianco","year":"2013","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.vhri.2025.101167_bib12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13023-017-0660-y","article-title":"The cost of severe haemophilia in Europe: the CHESS study","volume":"12","author":"O\u2019Hara","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.vhri.2025.101167_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13023-021-01774-9","article-title":"Clinical, humanistic, and economic burden of severe hemophilia B in the United States: results from the CHESS US and CHESS US+ population surveys","volume":"16","author":"Burke","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.vhri.2025.101167_bib14","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2015"},{"key":"10.1016\/j.vhri.2025.101167_bib15","author":"Bautista R\u00edos"},{"issue":"5","key":"10.1016\/j.vhri.2025.101167_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D: a measure of health status from the EuroQol Group","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann Med"},{"issue":"7","key":"10.1016\/j.vhri.2025.101167_bib17","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jval.2020.05.004","article-title":"Peruvian valuation of the EQ-5D-5L: a direct comparison of time trade-off and discrete choice experiments","volume":"23","author":"Augustovski","year":"2020","journal-title":"Value Health"},{"issue":"11","key":"10.1016\/j.vhri.2025.101167_bib18","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/jth.12672","article-title":"Definitions in hemophilia: communication from the SSC of the ISTH","volume":"12","author":"Blanchette","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"suppl 1","key":"10.1016\/j.vhri.2025.101167_bib19","first-page":"35","article-title":"\u201cProblem Joint\u201d: a more patient-relevant definition for joint morbidity in haemophilia","volume":"25","author":"O\u2019Hara","year":"2019","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.vhri.2025.101167_bib20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13023-022-02300-1","article-title":"Differential humanistic and economic burden of mild, moderate and severe haemophilia in European adults: a regression analysis of the CHESS II study","volume":"17","author":"Rodriguez-Santana","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.vhri.2025.101167_bib21","first-page":"189","article-title":"The challenge of patient adherence","volume":"1","author":"Martin","year":"2005","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"10.1016\/j.vhri.2025.101167_bib22","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/bjh.14072","article-title":"Adherence to prophylaxis and bleeding outcome in haemophilia: a multicentre study","volume":"174","author":"Schrijvers","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.vhri.2025.101167_bib23","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.2147\/PPA.S139851","article-title":"Treatment adherence in hemophilia","volume":"11","author":"Thornburg","year":"2017","journal-title":"Patient Prefer Adherence"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925000925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925000925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:47:06Z","timestamp":1762332426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109925000925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":22,"alternative-id":["S2212109925000925"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101167","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Severe Hemophilia on Costs and Quality of Life in South American Men: Findings From the CHESS LATAM Study","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101167"}}